MiNK Therapeutics, Inc. entered into a stock purchase agreement for issuance of 4,640,000 common shares at a price of $1.25 per share for gross proceeds of $5,800,000 on May 13, 2024. The transaction is expected to close on May 14, 2024, subject to customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9642 USD | -1.61% | -0.59% | -9.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.88% | 38.56M | |
+51.85% | 59.28B | |
+41.42% | 40.94B | |
-5.25% | 40.17B | |
-5.16% | 28.69B | |
+12.79% | 26.63B | |
-20.18% | 18.89B | |
+30.88% | 12.46B | |
+0.61% | 12.42B | |
+25.06% | 12.26B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- MiNK Therapeutics, Inc. announced that it expects to receive $5.8 million in funding